Document Detail

Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine.
MedLine Citation:
PMID:  9720729     Owner:  NLM     Status:  MEDLINE    
Vinorelbine (NVB) is a novel vinca alkaloid FDA approved for use in some advanced carcinomas. However, its role in non-Hodgkin's lymphoma (NHL) is still not well defined. NVB is an antimicrotubule agent, but as yet, it is not known whether it induces apoptosis. By flow cytometry using nuclear staining (propidium iodide) and annexin V, we demonstrated that NVB and vincristine (VCR) induced both mitotic arrest and apoptosis in leukemia and lymphoma cells, in a drug exposure time dependent manner. Cell cycle kinetics in 3 different cell lines varied during vinca alkaloid treatment. The annexin V method showed that apoptosis, as opposed to necrosis, was the dominant mode of cell kill of chemosensitive leukemia and lymphoma cells. Phosphatidylserine expression on the cell surface was detectable as a hallmark of apoptosis at earlier drug exposure when compared to conventional flow cytometry with PI staining. By Western blot analysis, we demonstrated that CPP32 or caspase-3, a critical apoptosis inducer, and its active subunits p20 and p11 were upregulated in chemo- and apoptosis-sensitive lymphoma and leukemia cells treated with NVB. Our data contributes to the emerging hypothesis suggesting that widely divergent exogenous stimuli and chemotherapeutic agents can effect apoptosis in cancer cells via different pathways involving the caspases. We believe that vinorelbine may be a potentially important drug in the treatment of NHL in the future.
H C Toh; L Sun; C H Koh; S E Aw
Related Documents :
16570349 - Cis-hydroxyproline-induced inhibition of pancreatic cancer cell growth is mediated by e...
20025279 - Anticancer effects of alpinia pricei hayata roots.
19112469 - Different sensitivity of neurons and neuroblastoma cells to quercetin treatment.
18197839 - Purification and antitumour activity of a lipopeptide biosurfactant produced by bacillu...
18175809 - Flow cytometry enumeration of apoptotic cancer cells by apoptotic rate.
19502099 - Staurosporine induces apoptosis in human papillomavirus positive oral cancer cells at g...
25431299 - Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxi...
9796719 - Tenosynovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopula...
2173429 - Comparison of anaplastic large cell ki-1 lymphomas and microvillous lymphomas in their ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  31     ISSN:  1042-8194     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-11-17     Completed Date:  1998-11-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  195-208     Citation Subset:  IM    
Department of Medical Oncology, Singapore General Hospital, Singapore.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Annexin A5 / analysis
Antineoplastic Agents, Phytogenic / therapeutic use*
Apoptosis / drug effects*
Burkitt Lymphoma / drug therapy*,  pathology
Caspase 3
Caspases / biosynthesis*
Cell Cycle / drug effects
Enzyme Induction
Flow Cytometry
Leukemia, T-Cell / drug therapy*,  pathology
Tumor Cells, Cultured
Vinblastine / analogs & derivatives*,  therapeutic use
Vincristine / therapeutic use*
Reg. No./Substance:
0/Annexin A5; 0/Antineoplastic Agents, Phytogenic; 57-22-7/Vincristine; 71486-22-1/vinorelbine; 865-21-4/Vinblastine; EC 3.4.22.-/CASP3 protein, human; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malig...
Next Document:  CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases.